Evidence lead: Ranks four through six · High appeal-filing share
Oscar Health MA: Appeals followed a large share of denials
626 appeals equal 15.0% of this contract's recorded denials. That is rank #4 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks four through six · High appeal-filing share
Appeals followed a large share of denials
626 appeals equal 15.0% of this contract's recorded denials. That is rank #4 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Bottom-seven record · Lower overturn-rate cohort
One of the ten lowest appeal overturn rates
62.0% of filed appeals were overturned, placing this record in the lowest-rate tier. Its overturn-rate rank is #33 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Bottom-seven record · Narrow reversal reach
Overturned appeals covered a small share of denials
9.3% of the plan's denials were ultimately overturned through the appeals counted here. The cross-contract rank is #33 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.
Bottom-seven record · Smaller request-volume cohort
One of the narrower authorization records
The source records 43,000 requests here, placing the contract in the smallest-volume tier. Its request-volume rank is #32 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks seven through ten · Higher denial-rate cohort
A top-ten denial rate in this source set
Oscar Health MA's 9.7% denial rate is in the highest group of the comparison. The exact rank is #8 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.